The Dermatology Devices Market is set to exceed USD 17 billion by 2024; according to a new research report by Global Market Insights.
Increasing incidence of skin associated diseases and disorders coupled with growing demand for cosmetic procedures are factors driving the global market. Growing number of new cases related to skin cancer and required diagnosis as well as treatment of skin cancer is anticipated to upsurge dermatology devices revenue. According to National Cancer Institute 2013-2015 data, around 2.3% of women and men will be diagnosed with melanoma of skin and in 2015, there were nearly 1.2 million individuals living with melanoma of skin in U.S.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2644
Diagnostic devices segment dominated and accounted for 57.0% in 2017, due to rising awareness of skin diseases and increasing number of diagnosis for skin problems. Treatment devices segment is projected to grow lucratively at a CAGR of 10.5% over the forecast timeline. The growth is attributable to escalating incidences of skin cancer coupled with rising expenditure on skin treatment.
Skin rejuvenation segment is anticipated to grow at a CAGR of 10.7% on an account of rising demand for cosmetic procedures coupled with advantages offered by skin rejuvenation treatment. Advantages such as reduction in pore sizes, improves appearance of acne scars, age spots, it also smooths fine lines, wrinkles and improves skin texture and tone. Additionally, skin rejuvenation treatment also stimulates collagen, it is cost-effective and is done by minimally invasive method. Such factors encourage customer buying behaviour thereby, fuels dermatology devices market growth.
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
- Brymill Cryogenic Systems
- Cortex Technology ApS
- Dansys Medical Group
- Ellipse A/S
- Genesis Biosystems
- HEINE Optotechnik
- Michelson Diagnostics Ltd.
- Solta Medical, Inc.
- Hologic, Inc.
- Ellipse A/S
- 3Gen, Inc.
- Syneron Candela
- alsa apparecchi medicali srl
- Cutera, Inc.
- Ambicare Health Ltd
- AMD Global Telemedicine, Inc.
- Biolitec Italia Srl
Skin cancer accounted for more than 26% industry share in 2017 and is projected to continue its dominance over the coming years. Increasing incidence of skin cancer coupled with advancing technology for treatment of skin cancer is anticipated to propel dermatology devices market growth. According to Australian Government Cancer statistics 2017, around 10.4% individuals were diagnosed with melanoma skin cancer.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2644
U.S. market held over 92% industry share in 2017 with its market growth attributed to factors such as, escalating incidence of skin cancer and skin associated diseases and surging demand for cosmetic procedures. Furthermore, availability of advanced treatment options, increasing awareness regarding skin diseases and willingness to spend more for skin problems are aspects projected to boost market growth.
Dermatology Devices Market by Product Type
- Diagnostic Devices
- Imaging Devices
- Biopsy Devices
- Treatment Devices
- Light Therapy Devices (LED Therapy)
- Microdermabrasion Devices
- Cryotherapy Devices
- Electrosurgical Equipment
- Liposuction Devices